BPC 157
Cytoprotective peptide
Informational content • Not medical advice • For research purposes only
Overview
Support for tissue integrity and adaptive repair.
Cytoprotective peptide
Support for tissue integrity and adaptive repair.
Mechanism of action
A careful product description should frame BPC 157 as: a research peptide with extensive preclinical literature, limited human evidence, and significant regulatory and sport restrictions.
Sport and regulatory: Anti doping authorities (e.g., USADA) describe BPC 157 as prohibited under the WADA Prohibited List as an unapproved substance, and they emphasize uncertainty around safe human use due to limited clinical study.
Human evidence: Published literature frequently emphasizes that human data are limited, and that many strong claims circulating online are not yet clinically proven.
BPC 157 (“Body Protection Compound”) is a 15 amino acid peptide originally described in the context of peptides found in gastric juice and studied for broad effects in preclinical models of tissue injury, inflammation, and healing biology. Mechanistic research has explored potential interactions with nitric oxide signaling, growth factor pathways, angiogenesis related processes, and inflammatory mediators—but these mechanistic narratives are largely built from cell and animal studies, not large, definitive human trials.
Authenticity
To validate your product, scan the QR code on the packaging or open the verification page for this product group.